Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP372353.RApTgmI7Wb9qA7jT9Z-62o2y41dAmKcgVeNeCAA0mnZUs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP372353.RApTgmI7Wb9qA7jT9Z-62o2y41dAmKcgVeNeCAA0mnZUs130_assertion type Assertion NP372353.RApTgmI7Wb9qA7jT9Z-62o2y41dAmKcgVeNeCAA0mnZUs130_head.
- NP372353.RApTgmI7Wb9qA7jT9Z-62o2y41dAmKcgVeNeCAA0mnZUs130_assertion description "[By immunohistochemical analyses of 148 tissues from 89 prostate cancer patients, we now show that both eIF4E expression and 4E-BP1 phosphorylation (p4E-BP1) are increased significantly, particularly in advanced prostate cancer versus benign prostatic hyperplasia tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372353.RApTgmI7Wb9qA7jT9Z-62o2y41dAmKcgVeNeCAA0mnZUs130_provenance.
- NP372353.RApTgmI7Wb9qA7jT9Z-62o2y41dAmKcgVeNeCAA0mnZUs130_assertion evidence source_evidence_literature NP372353.RApTgmI7Wb9qA7jT9Z-62o2y41dAmKcgVeNeCAA0mnZUs130_provenance.
- NP372353.RApTgmI7Wb9qA7jT9Z-62o2y41dAmKcgVeNeCAA0mnZUs130_assertion SIO_000772 19383915 NP372353.RApTgmI7Wb9qA7jT9Z-62o2y41dAmKcgVeNeCAA0mnZUs130_provenance.
- NP372353.RApTgmI7Wb9qA7jT9Z-62o2y41dAmKcgVeNeCAA0mnZUs130_assertion wasDerivedFrom befree-20150227 NP372353.RApTgmI7Wb9qA7jT9Z-62o2y41dAmKcgVeNeCAA0mnZUs130_provenance.
- NP372353.RApTgmI7Wb9qA7jT9Z-62o2y41dAmKcgVeNeCAA0mnZUs130_assertion wasGeneratedBy ECO_0000203 NP372353.RApTgmI7Wb9qA7jT9Z-62o2y41dAmKcgVeNeCAA0mnZUs130_provenance.